Today: 23 January 2026
Subscribe
Browse Category

Investments News 23 June 2025

Fueling the Future: Inside the $8 Billion In-Orbit Satellite Servicing Boom by 2034

Fueling the Future: Inside the $8 Billion In-Orbit Satellite Servicing Boom by 2034

The global in-orbit servicing market is forecast to grow from about $2.4–$2.7 billion in the mid-2020s to roughly $8 billion by 2034, a CAGR of about 11–12%. Northrop Grumman SpaceLogistics’ Mission Extension Vehicle, MEV-1, docked to Intelsat-901 in 2020, restoring operations and extending life by more than 5 years. MEV-2 docked with IS-10-02 in 2021, following MEV-1, demonstrating repeatable life-extension…
23 June 2025
·
1 … 63 64 65

Stock Market Today

  • Oric Pharmaceuticals Shares Poised for 74% Upside as Biotech Innovation Draws Investor Attention
    January 23, 2026, 8:13 AM EST. Oric Pharmaceuticals (NASDAQ: ORIC) is gaining investor interest with a potential 74% upside from its current $12.05 share price, backed by partnerships with Pfizer, Bayer, and Johnson & Johnson. The clinical-stage biotech focuses on therapies addressing cancer treatment resistance, advancing candidates like ORIC-114 and ORIC-944 through early-stage trials. Despite a $1.17 billion market cap, Oric reports a negative EPS of -1.71 and free cash flow of -$70.7 million, reflecting typical high-risk biotech dynamics. With no dividends and a neutral RSI, stock momentum shows cautious optimism. Analysts rate ORIC with 14 buys and project a $21 average target price, suggesting substantial growth for investors able to tolerate the sector's inherent uncertainties.
Go toTop